My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

ACADIA Pharmaceuticals Inc. - Common Stock (NQ:ACAD)

23.53 +0.07 (+0.30%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ACADIA Pharmaceuticals Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Looking into ACADIA Pharmaceuticals's Return on Capital Employed ↗

August 20, 2021

After pulling data from Benzinga Pro it seems like during Q2, ACADIA Pharmaceuticals's (NASDAQ:ACAD) reported sales totaled $115.22 million. Despite a 34.54% in earnings, the...

Via Benzinga

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business ↗

August 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...

Via Benzinga

Is It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021? ↗

August 12, 2021

One particular group of stocks is overrepresented among the exchange's biggest losers this year. That's an important detail.

Via The Motley Fool

Acadia Pharmaceuticals Inc (ACAD) Q2 2021 Earnings Call Transcript ↗

August 06, 2021

ACAD earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Acadia Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021

August 05, 2021

From Acadia Pharmaceuticals Inc.

Via Business Wire

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗

August 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗

August 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 10, 2021

Before 10 a.m. ET on Tuesday, 60 companies set new 52-week lows. Key Facts: PACCAR (NASDAQ:PCAR) was the biggest company by market cap to set a new 52-week low....

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 05, 2021

Gainers Ensysce Biosciences (NASDAQ:ENSC) shares rose 42.78% to $5.84 during Thursday's pre-market session. The company's market cap stands at $141.7 million....

Via Benzinga

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

99 Biggest Movers From Yesterday ↗

August 06, 2021

Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a...

Via Benzinga

26 Stocks Moving in Thursday's Pre-Market Session ↗

August 05, 2021

Gainers Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares rose 34% to $5.48 in pre-market trading after dropping around 15% on Wednesday. Ensysce Biosciences recently appointed...

Via Benzinga

10 Stocks Moving In Wednesday's After-Hours Session ↗

August 04, 2021

Gainers MercadoLibre (NASDAQ: MELI) shares are trading higher after the company reported Q2 EPS of $1.37, up from $1.11 year over year and better-than-expected Q2 sales results....

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 04, 2021

Gainers Scopus BioPharma (NASDAQ:SCPS) s...

Via Benzinga

Acadia Pharmaceuticals Reports Second Quarter 2021 Financial Results

August 04, 2021

From Acadia Pharmaceuticals Inc.

Via Business Wire

9 Monster Stock Market And Earnings Predictions – Sunday, August 1 ↗

August 01, 2021

Stocks finished the week of July 30 lower, dropping by 40 bps and while the S&P 500 didn’t finish down all that much, we could wonder if last week served as a turning point for the market overall.

Via Talk Markets

Topics Stocks

The New England Journal of Medicine Publishes Results from the Phase 3 HARMONY Study Evaluating Pimavanserin in Patients with Dementia-Related Psychosis

July 21, 2021

From Acadia Pharmaceuticals Inc.

Via Business Wire

Acadia Pharmaceuticals to Announce Second Quarter 2021 Financial Results on August 4, 2021

July 21, 2021

From Acadia Pharmaceuticals Inc.

Via Business Wire

Understanding ACADIA Pharmaceuticals's Unusual Options Activity ↗

July 19, 2021

Shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved down to $23.25. Sentiment:...

Via Benzinga

Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the Alzheimer’s Association International Conference 2021 (AAIC)

July 14, 2021

From Acadia Pharmaceuticals Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 01, 2021

Gainers Alterity Therapeutics (NASDAQ:ATHE

Via Benzinga

DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 21, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 20, 2021

From The Schall Law Firm

Via Business Wire

MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 19, 2021

From The Schall Law Firm

Via Business Wire

DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 18, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 17, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Acadia Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

June 16, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.